Status:
RECRUITING
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
Lead Sponsor:
Linkoeping University
Conditions:
Tuberculosis
Immunologic Activity Alteration
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about how the blood leucocytes from patients with and without exposure or disease from tuberculosis (TB) are able to kill live mycobacteria (M. tubercu...
Detailed Description
Background: The host immune response is crucial in determining the outcome after exposure to Mtb. A substantial proportion of exposed individuals (40-70%) never develop infection indicating an efficie...
Eligibility Criteria
Inclusion
- Healthy blood donors or subjects who will get vaccinated.
Exclusion
- Known HIV infection, not Swedish citizen, chronic liver och kidney disease,immunosuppression from treatment or disease.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT06580639
Start Date
August 1 2020
End Date
December 1 2025
Last Update
August 30 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kalmar County Hospital
Kalmar, Sweden, 391 85
2
Dept of Infectious Diseases
Linköping, Sweden, 581 85